Table:
begin	end	state
1	15	non-cytoplasmic
16	39	transmembrane
40	44	non-cytoplasmic
45	72	transmembrane
73	73	non-cytoplasmic
74	108	cytoplasmic
109	134	transmembrane
135	139	non-cytoplasmic
140	163	transmembrane
164	170	cytoplasmic
171	193	transmembrane
194	204	non-cytoplasmic
205	225	transmembrane
226	248	cytoplasmic
249	281	transmembrane
282	303	non-cytoplasmic
304	325	transmembrane
326	328	cytoplasmic
329	350	transmembrane
351	355	non-cytoplasmic
356	376	transmembrane
377	384	cytoplasmic
385	428	transmembrane
429	433	cytoplasmic
434	451	transmembrane
452	466	non-cytoplasmic
467	490	transmembrane
491	504	cytoplasmic

Input:
>AO356_04625
MDTLNYLGQGFGVALTPYNLVTALTGTLIGTVVGLLPGLGPINGVALLIPIAFALGLPPE
SALILLAAVYLGCEYGGRISSILLNIPGEASTVMTTLDGYPMARQGLAGVALSLSAWSSF
IGAFIATCGMVLFAPLLAKWAIAFGPAEYFVLMVFAIVCLGGMAGDRPLKTFIAALIGLF
LSSVGIDANSGVYRFTGDNIHLTDGIQFVVLVLGLFSISEILLLLEKTHRGQEAVEATGR
MMFNFKEAASVFVVNLRCGVLGFIMGVLPGAGATLASAVAYMTEKRIAGASGKFGQGDKR
GLAAPETAIGGAACGALVPMLTLGVPGSGTTAVMIGALSLYNITPGPLLFQQQPDIVWGL
IASLFVANIMLVILNIPMIRIFTRILAVPNWALVPVIAIITGIGVYAVHATTFDLFLMIG
IGIFGYILRKLDFPLSPVLLGFILGGLMEQNLRRALSISNGALEILWSSPITFGCWILTA
IMLFMPLLRIWRRRAAQRRALANV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server